| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |